Sarah Maguire, Alice Kesby, Rachel Brownlow, Glenn E Hunt, Marcellius Kim, Claire McAulay, Jessica R Grisham, Iain S McGregor, Anastasia Suraev, Richard C Kevin, Janice Russell
BACKGROUND: Anorexia nervosa (AN) is an eating disorder (ED) with high mortality rates and limited response to existing treatments, prompting the need to identify effective agents and adjuncts. There is evidence for an emerging role for the neuropeptide oxytocin (OT) in the pathophysiology of AN, with studies showing a perturbed oxytocinergic system in patients with AN. Preliminary evidence has demonstrated that intranasal OT (IN-OT) can produce anxiolytic effects in AN, as well as reducing concern about eating, and dysfunctional attentional biases related to the disorder...
March 19, 2024: Psychoneuroendocrinology